Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity.
about
Trabectedin and Campthotecin Synergistically Eliminate Cancer Stem Cells in Cell-of-Origin Sarcoma ModelsTreatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations.Advances in the Treatment of Pediatric Bone Sarcomas.Ewing sarcoma partial regression without GvHD by chondromodulin-I/HLA-A*02:01-specific allorestricted T cell receptor transgenic T cells.Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy.
P2860
Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trabectedin Followed by Irinot ...... omas with Acceptable Toxicity.
@en
Trabectedin Followed by Irinot ...... omas with Acceptable Toxicity.
@nl
type
label
Trabectedin Followed by Irinot ...... omas with Acceptable Toxicity.
@en
Trabectedin Followed by Irinot ...... omas with Acceptable Toxicity.
@nl
prefLabel
Trabectedin Followed by Irinot ...... omas with Acceptable Toxicity.
@en
Trabectedin Followed by Irinot ...... omas with Acceptable Toxicity.
@nl
P2093
P2860
P50
P356
P1433
P1476
Trabectedin Followed by Irinot ...... omas with Acceptable Toxicity.
@en
P2093
F von Klot-Heydenfeldt
I von Luettichau
J Van den Brande
P J Grohar
St Burdach
W E Berdel
P2860
P304
P356
10.1155/2016/7461783
P577
2016-10-24T00:00:00Z